Lacosam 150 Tablet contains Lacosamide 150mg, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing without affecting normal neuronal excitability. This mechanism contributes to its efficacy in reducing seizure frequency. Lacosam 150 is administered orally and is typically initiated at a lower dose with gradual titration to minimize adverse effects. It may be used as monotherapy or as adjunctive therapy in adults and pediatric patients aged 4 years and above. Common adverse reactions include dizziness, headache, nausea, and diplopia, which are generally mild to moderate in intensity. Caution is advised in patients with cardiac conduction abnormalities, as Lacosamide can prolong PR interval. Regular monitoring of cardiac function and electrocardiograms is recommended in high-risk individuals. Dose adjustments may be necessary in patients with renal or hepatic impairment. Lacosam 150 should be used under medical supervision, with adherence to prescribed dosing to optimize therapeutic outcomes and minimize potential side effects. It is contraindicated in patients with known hypersensitivity to Lacosamide or any excipients.